[c09aa8]: / clusters / 9knumclustersv2 / clust_1169.txt

Download this file

40 lines (39 with data), 4.7 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Clinically significant gastrointestinal disorders.
Clinically significant gastrointestinal disorders
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
Clinically significant gastrointestinal conditions or disorders that may interfere with study drug absorption, including prior gastrectomy
Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug.
Clinically significant gastrointestinal conditions or disorders that may interfere with study drug absorption, including prior gastrectomy
Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug
Clinically significant gastrointestinal disorders
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Patients who have gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug are not eligible
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
History of gastrointestinal disorders that may interfere with the absorption of study drug (including gastric bypass surgery)
Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug
Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug
Gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
History of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of oral study drug(s) within months of enrollment
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
Clinically significant gastrointestinal disorders that may interfere with absorption of drug
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Clinically significant gastrointestinal disorders that may interfere with absorption of drug.
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Significant gastrointestinal disorders that may interfere with absorption of tosedostat.
Gastrointestinal disorders that may significantly interfere with absorption of study drug
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug as determined by the investigator
Patients with significantly diseased or obstructed gastrointestinal tract or uncontrolled vomiting or diarrhea or other gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Significant gastrointestinal disorders, in the opinion of the Investigator
Gastrointestinal disorders or abnormalities that would interfere with absorption of study drug
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Patients with gastrointestinal disorders or abnormalities that would interfere with absorption of study treatment.
Patients with a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents
Any gastrointestinal disorders which may interfere with the absorption of oseltamivir
Gastrointestinal disorders that would interfere with drug absorption
History of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agent
Gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug
Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of ranolazine
History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of orally administered hormonal agents